drugset / Trial / NCT01711125

Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease

NCT01711125

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To explore the effectiveness and biobehavioural basis of baclofen in improving treatment outcomes for alcohol dependence in people with or without alcoholic cirrhosis in a double-blind randomised placebo-controlled trial.

Timeline

Start
2013-03
Primary completion
2017-06
Completion
2017-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 30 mg
Subject Baclofen Small molecule 75 mg